Ico-Badalona

Badalona 89016

2 studies enrolling now · 6 studies all time

What they study most

Acute Myeloid Leukemia (AML), Breast Cancer, Chronic Lymphocytic Leukemia, Endometrial Cancer, Marginal Zone Lymphoma, Ovarian Cancer, Relapsed/Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma

Studies at this site

• A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma — Recruiting now
• Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression — Recruiting now
• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling
• PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
• Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma — Running, not enrolling
• Selinexor (KPT-330) in Older Patients With Relapsed AML — Completed